Reverse Transcriptase Inhibitors: all 1,328 studies that test it

Page 11 of 14. Open to participants first (42), then studies with results posted, then the rest; newest registration first within each.

• Tenofovir Disoproxil Fumarate in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drug CombinationsStatus unknownNCT00011089Not applicable
• Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral DrugsStatus unknownNCT00009061Phase 3
• Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug TherapyWithdrawnNCT00008866Phase 2
• Comparing Side Effects of Two Forms of Videx in HIV-Infected AdultsStatus unknownNCT00008489Phase 3
• The Safety of Tenofovir Disoproxil Fumarate Taken With Other Anti-HIV Drugs to Treat HIV-Infected PatientsStatus unknownNCT00007436Phase 3
• Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected PatientsCompletedNCT00006617Not applicable
• Capravirine to Treat Children With HIV InfectionCompletedNCT00006519Phase 1
• Oltipraz in the Prevention of Lung Cancer in People Who SmokeCompletedNCT00006457Phase 1
• Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIVCompletedNCT00006441Not applicable
• Differences Between Women and Men Taking a Combination of Indinavir, Ritonavir, Enteric-Coated Didanosine, and Stavudine Who Previously Took Anti-HIV DrugsStatus unknownNCT00006397Phase 3
• Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their NewbornsCompletedNCT00006396Phase 3
• The Safety of Nevirapine When Given to Breast-Feeding Babies From Birth to Age 6 MonthsCompletedNCT00006279Phase 1
• Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System LymphomaCompletedNCT00006264Phase 2
• A Study of Capravirine Plus VIRACEPT Plus Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Who Failed Previous Anti-HIV TreatmentsCompletedNCT00006211Phase 2
• A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV DrugsStatus unknownNCT00006208Phase 3
• A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV InfectionCompletedNCT00006154Phase 3
• Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected PatientsCompletedNCT00005918Phase 3
• Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative VolunteersCompletedNCT00005762Not applicable
• Safety and Anti-HIV Activity of Capravirine Alone and in Combination With Other Anti-HIV DrugsCompletedNCT00005673Phase 1
• A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected PatientsCompletedNCT00005106Phase 4
• Safety and Effectiveness of a Combination Anti-HIV Drug TreatmentCompletedNCT00005018Phase 4
• Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV DrugsStatus unknownNCT00005000Phase 4
• Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected PatientsSuspendedNCT00004999Phase 2
• Combination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Patients Who Failed Initial Combination TherapyCompletedNCT00004985Phase 2
• Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)Status unknownNCT00004981Phase 3
• Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV DrugsCompletedNCT00004855Not applicable
• Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV DrugsCompletedNCT00004852Phase 2
• A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected AdultsCompletedNCT00004585Phase 4
• A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug TherapyCompletedNCT00004583Phase 3
• ABT-378/Ritonavir and Efavirenz in HIV-Infected Patients Who Have Taken More Than One Protease Inhibitor in the PastCompletedNCT00004582Phase 2
• A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV TreatmentCompletedNCT00004581Phase 3
• Chemotherapy and Radiation Therapy in Treating Patients With HIV-Related Primary Central Nervous System LymphomaStatus unknownNCT00003261Phase 2
• A Compassionate Use Study of Tenofovir Disoproxil Fumarate as Treatment for HIV InfectionCompletedNCT00002453Not applicable
• Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV DrugsStatus unknownNCT00002451Phase 2
• Safety and Effectiveness of Tenofovir Disoproxil Fumarate (Tenofovir DF) Plus Other Anti-HIV Drugs in HIV-Infected PatientsCompletedNCT00002450Phase 3
• A Study to Compare the Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected PatientsCompletedNCT00002448Phase 3
• A Study to Compare Two Anti-HIV Drug CombinationsCompletedNCT00002447Phase 3
• The Safety and Effectiveness of MK-639 and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Never Taken Anti-HIV DrugsCompletedNCT00002443Not applicable
• A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV DrugsCompletedNCT00002442Phase 2
• The Safety and Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Taken AZTCompletedNCT00002436Phase 3
• A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDSCompletedNCT00002432Not applicable
• Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug RegimenCompletedNCT00002429Phase 3
• Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected AdultsCompletedNCT00002427Phase 1
• A Study on the Safety and Effectiveness of Adefovir Dipivoxil in Combination With Anti-HIV Therapy (HAART) in HIV-Positive PatientsCompletedNCT00002426Not applicable
• A Study to Compare the Safety and Effectiveness of Indinavir Combined With Stavudine and LamivudineSuspendedNCT00002424Phase 2
• A Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include AmprenavirCompletedNCT00002423Phase 2
• The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease InhibitorsTerminatedNCT00002420Phase 2
• Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor TreatmentCompletedNCT00002419Phase 2
• The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease InhibitorsTerminatedNCT00002418Phase 2
• Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug CombinationCompletedNCT00002416Phase 3
• Safety and Effectiveness of Adding PMPA Prodrug to an Anti-HIV Drug Combination to Treat HIV-Infected PatientsCompletedNCT00002415Phase 2
• A Study of MKC-442 in HIV-Positive PatientsCompletedNCT00002413Phase 2
• A Study of MKC-442 in Combination With Other Anti-HIV DrugsCompletedNCT00002412Phase 2
• A Study of Three Different Anti-HIV Drug Combinations in HIV-Infected PatientsCompletedNCT00002410Phase 3
• The Effect of Teaching HIV-Infected Patients About HIV and TreatmentCompletedNCT00002409Phase 3
• A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected PatientsCompletedNCT00002401Not applicable
• A Study of Two Anti-HIV Drug Combinations in HIV-Infected PatientsCompletedNCT00002400Not applicable
• Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug CombinationsCompletedNCT00002398Not applicable
• The Safety and Effectiveness of PMPA Prodrug in HIV-Infected PatientsStatus unknownNCT00002396Phase 1
• The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 DrugsCompletedNCT00002391Phase 3
• A Study of the Safety and Effectiveness of Different Doses of 1592U89 in HIV-Infected PatientsCompletedNCT00002390Phase 2
• The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV DrugsCompletedNCT00002389Phase 3
• A Study of 1592U89 in HIV-Infected PatientsCompletedNCT00002388Phase 1
• The Safety and Effectiveness of Indinavir Sulfate Plus EfavirenzCompletedNCT00002387Not applicable
• The Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken StavudineCompletedNCT00002381Phase 1
• The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV DrugsCompletedNCT00002379Phase 2
• The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken ZidovudineCompletedNCT00002371Phase 3
• The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV DrugsCompletedNCT00002368Phase 3
• A Study of Saquinavir Soft Gelatin Capsules Plus Zidovudine Plus Lamivudine in the Treatment of HIV-1 Infected Patients Who Have Never Taken Anti-HIV DrugsCompletedNCT00002367Phase 3
• A Study of 1592U89 Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV DrugsCompletedNCT00002364Phase 2
• A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV DrugsSuspendedNCT00002362Phase 3
• A Study Comparing Two Forms of Didanosine in HIV-infected PatientsCompletedNCT00002360Phase 1
• A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive PatientsCompletedNCT00002354Not applicable
• A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection.CompletedNCT00002349Not applicable
• The Safety and Effectiveness of Retrovir Plus HIVID Combined With Either Nevirapine or Invirase in the Treatment of HIV InfectionCompletedNCT00002347Phase 2
• The Safety and Effectiveness of Bis-POM PMEA in HIV-Infected PatientsCompletedNCT00002346Phase 1
• The Safety and Effectiveness of 524W91CompletedNCT00002335Phase 1
• A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous TreatmentCompletedNCT00002334Phase 3
• A Study of Saquinavir and Zalcitabine, Used Alone and Together, in the Treatment of Advanced HIV Infection in Patients Who Stopped Taking or Who Cannot Take ZidovudineCompletedNCT00002333Phase 2
• The Safety and Effectiveness of Zidovudine Plus Adefovir in HIV-Infected PatientsCompletedNCT00002326Phase 1
• The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the DiseaseCompletedNCT00002324Phase 2
• A Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Virologic and Immunologic Activities of 400 Mg Nevirapine in Combination With Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 4-12 Months of Prior Zidovudine Therapy and 200-500 CD4+ CellCompletedNCT00002323Not applicable
• A Study of Different Doses of Atevirdine Mesylate Plus Zidovudine in HIV-Positive PatientsCompletedNCT00002322Phase 2
• A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the PastCompletedNCT00002320Phase 3
• The Safety and Effectiveness of U-90152 in HIV-1 Infected Patients Who Take ZidovudineCompletedNCT00002312Not applicable
• A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV DrugsCompletedNCT00002308Not applicable
• A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected PatientsCompletedNCT00002307Not applicable
• A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Have Not Had Success With GanciclovirStatus unknownNCT00002301Not applicable
• The Safety and Effectiveness of Zidovudine Plus Acyclovir in Patients With Early HIV InfectionCompletedNCT00002290Not applicable
• The Safety and Effectiveness of Retrovir in HIV-Infected Patients Who Have Problems Related to the Nervous SystemCompletedNCT00002288Not applicable
• A Study of Retrovir in the Prevention of HIV Infection in Health Care Workers Accidentally Exposed to the VirusCompletedNCT00002287Not applicable
• A Study of Retrovir in the Treatment of Psoriasis in HIV-Positive PatientsCompletedNCT00002286Not applicable
• A Study of Zidovudine and T Lymphocyte Transfer in the Treatment of HIV Type III in Patients With AIDSCompletedNCT00002285Not applicable
• A Study of Azidothymidine (AZT) in the Treatment of HIV Infection in Patients Receiving a Bone Marrow TransplantCompletedNCT00002284Not applicable
• A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients With AIDS or AIDS-Related ComplexCompletedNCT00002281Not applicable
• A Study of ddI in Children With AIDS Who Have Not Had Success With ZidovudineCompletedNCT00002280Not applicable
• A Study of ddC in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Have Not Had Success With Zidovudine (AZT)CompletedNCT00002279Not applicable
• A Study of ddI in Patients With AIDS Who Become Sicker While Taking ZidovudineCompletedNCT00002274Not applicable
• An Open, Multicenter Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other ImmunodeficienciesCompletedNCT00002272Not applicable
• A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 InfectionCompletedNCT00002270Not applicable

← Reverse Transcriptase Inhibitors overview